Skip to main content

MoneyWorks4Me

Lupin informs about press release

13 Nov 2018 Evaluate

Lupin has informed about a Press Release as regards receipt of USFDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampules, to market a generic version of AstraZeneca Pharmaceuticals LP's (AstraZeneca) Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..